Role of the liver-enriched transcription factor hepatocyte nuclear factor 1 in transcriptional regulation of the factor VIII gene

Molecular and Cellular Biology

Volumn 16, Issue 5, 1996, Pages 1936-1945

  McGlynn, L K ^a   Mueller, C R ^a   Begbie, M ^a   Notley, C R ^a   Lillicrap, D ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; NUCLEAR FACTOR I;

ARTICLE; GENE DELETION; GENE SEQUENCE; HEMOPHILIA A; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 0029963548     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.16.5.1936     Document Type: Article

References (60)

1. Bach, I., M. G. Mattei, S. Cereghini, and M. Yaniv. 1991. Two members of an HNF-1 homeoprotein family are expressed in human liver Nucleic Acids Res. 19:3553-3559.
2. Berg, L.-P., D. White, V. V. Kakkar, and D. N. Cooper. 1993 Functional characterization of a promoter mutation in the protein C gene. Thromb. Haemostasis 69:999a.
3. Bontempo, F. A., J. H. Lewis, T. J. Gorene, J. A. Spero, M. V. Ragni, J. P. Scott, and T. E. Starzl. 1987. Liver transplantation in hemophilia A. Blood 69:1721-1724.
4. Briet, E., R. M. Bertina, N. H. van Tilburg, and J. J. Veltkamp. 1982 Hemophilia B Leyden. a sex-linked hereditary disorder that improves after puberty. N. Engl. J. Med. 306:788-790.
5. Courtois, G., S. Baumhueter, and G. R. Crabtree. 1988. Purified hepatocyte nuclear factor 1 interacts with a family of hepatocyte specific promoters Proc. Natl. Acad Sci. USA 85:7937-7941.
6. Crossley, M., and G. G. Brownlee. 1990. Disruption of a C/EBP binding site in the factor IX promoter is associated with hemophilia B. Nature (London) 345:444-446.
7. Crossley, M., P. R. Winship, D. E. G. Austen, C. R. Rizza, and G. G. Brownlee. 1990. A less severe form of haemophilia B Leyden Nucleic Acids Res. 18:4633
8. Dorner, A. J., D. G. Bole, and R. J. Kaufman. 1987. The relationship of N-linked glycosylation and heavy chain-binding protein association with the secretion of glycoproteins. J. Cell Biol 105:2665-2674.
9. Dorner, A. J., L. C. Wasley, and R. J. Kaufman. 1990. Protein dissociation from GRP78 and secretion are blocked by depletion of cellular ATP levels. Proc. Natl. Acad. Sci. USA 87:7429-7432.
10. S mutation. Blood 79:787-792.
11. Figueiredo, M. S., and G. G. Brownlee. 1995. cis-acting elements and transcription factors involved in the promoter activity of the human factor VIII gene. J. Biol Chem. 270:11828-11838.
12. Freedenburg, D. L., and B. Black. 1991 Altered developmental control of the factor IX gene: a new T to A mutation at position +6 of the factor IX gene resulting in hemophilia B Leyden. Thromb. Haemostasis 65:964a.
13. Friedman, A. D., W. H. Landschultz, and S. L. McKnight. 1989. CCAAT/ enhancer binding protein activates the promoter of the serum albumin gene in cultured hepatoma cells. Genes Dev. 3:1314-1322
14. Gitschier, J., W. I. Wood, T. M. Goralka, K. L. Wion, E. Y. Chen, D. H. Eaton, G. A. Vehar, D. J. Capon, and R. M. Lawn. 1984. Characterization of the human factor VIII gene. Nature (London) 312:326-330.
15. Gorski, K., M. Carneiro, and U. Schibler. 1986. Tissue-specific in vitro transcription from the mouse albumin promoter. Cell 47:767-776.
16. Grant, D. J., and N. Maeda. 1993. A base substitution in the promoter associated with the human haptoglobin 2-1 modified phenotype decreases transcriptional activity and responsiveness to interleukin-6 in human hepatoma cells. Am. J Hum. Genet. 52:974-980.
17. Gregori, C., A. Kahn, and A.-L. Pichard. 1993. Competition between transcription factors HNF-1 and HNF-3, and alternative cell-specific activation by DBF and C/EBP contribute to the regulation of the liver-specific aldolase B promoter. Nucleic Acids Res. 21:897-903.
18. Higuchi, M., C. Wong, L. Kochhan, K. Olek, S. Aronis, C. K. Kasper, H. H. Kazazian, Jr., and S. E. Antonarakis. 1990. Characterization of mutations in the factor VIII gene by direct sequencing of amplified genomic DNA Genomics 6:65-71.
19. Hirosawa, S., J. B. Fahner, J.-P. Salier, C.-T. Wu, E. W. Lovrien, and K. Kurachi. 1990 Structural and functional basis of the developmental regulation of human coagulation factor IX gene: factor IX Leyden Proc. Natl Acad. Sci USA 87:4421-4425.
20. Hoyer, L. W. 1981. The FVIII complex, structure and function. Blood 58:1-13.
21. Kaufman, R. J., L. C. Wasley, M. V. Davies, R. J. Wise, D. I. Israel, and A. J. Dorner. 1989. Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells. Mol. Cell. Biol9:1233-1242.
22. Kaufman, R. J., L. C. Wasley, and A. J. Dorner. 1988. Synthesis, processing, and secretion, of recombinant human factor VIII expressed in mammalian cells. J. Biol. Chem. 263:6352-6362.
23. Lee, Y.-H., J. A. Alberta, F. J. Gonzalez, and D. J. Waxman. 1994. Multiple, functional DBP sites on the promoter of the cholesterol 7α-hydroxylase P450 gene CYP7. J. Biol. Chem. 269:14681-14689.
24. Lewis, J. H., F. A. Bontempo, J. A. Sperio, M. V. Ragni, and T. E. Starzl. 1985. Liver transplantation in a hemophiliac. N. Engl. J. Med. 312:1189-1190.
25. Lichtsteiner, S., J. Wuarin, and U. Schibler. 1987. The interplay of DNA binding proteins on the promoter of the mouse albumin gene Cell 51:963-973
26. Lillicrap, D., et al. Unpublished data.
27. Ljung, R., and I. M. Nilsson. 1982. Hemophilia B Leyden and a similar variant of hemophilia A. N. Engl J. Med 307:897-898.
28. Ludwig, M., R. Schwaab, A. Eigel, J. Horst, H. Egli, H. H. Brackmann, and K. Olek. 1989. Identification of a single nucleotide C to T transition and five different deletions in patients with severe hemophilia B. Am. J. Hum. Genet. 45:115-122.
29. Maire, P., J. Wuarin, and U. Schibler. 1989. The role of cis-acting promoter elements in tissue-specific albumin gene expression. Science 244:343-345.
30. McKnight, S. L. 1992. CCAAT/enhancer binding protein, p. 771-792. In S. L McKnight (ed.), Transcriptional regulation. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
31. Meloni, A., M. C. Rosatelli, V. Faa, R. Sardu, L. Saba, S. Murru, G. V. Sciarratta, M. Baldi, N. Tannoia, A. Vittucci, and A. Cao. 1992. Promoter mutations producing mild beta-thalassaemia in the Italian population. Br. J Haematol. 80:222-226
32. Mendel, D. B., L. P. Hansen, M. K. Graves, P. B. Conley, and G. R. Crabtree. 1991. HNF-1α and HNF-1β (vHNF-1) share dimenzation and homeo domains, but not activation domains, and form heterodimers in vitro. Genes Dev. 5:1042-1056.
33. Minty, A., and L. Kedes. 1986. Upstream regions of the human cardiac actin genes that modulate its transcription in muscle cells: presence of an evolutionarily conserved repeated motif. Mol. Cell. Biol. 6:2125-2136
34. Mueller, C. R. 1992. The down-regulation of albumin transcription during regeneration is due to the loss of HNF-1 and D-site transcription factors DNA Cell Biol. 11:559-566.
35. Mueller, C. R., et al. Unpublished data
36. Murru, S., M. C. Pischedda, A. Cao, M. C. Rosatelli, M. Pirastu, G. V. Sciarratta, L. Manca, D. Gablisai, and C. Toffoli. 1993. A promoter mutation in the β-globin gene (-101 C→T) has an age-related expression pattern. Blood 81:2818-2819.
37. Orkin, S. H., S. E. Antonarakis, and H. H. Kazazian, Jr. 1984. Base substitution at position -88 in a beta thalassemia globin gene further evidence for the role of distal promoter element ACACCC. J. Biol Chem. 259:8679-8681.
38. Orkin, S. H., J. P. Sexton, T. C. Cheng, S. C. Goff, P. J. V. Giardina, J. I. Lee, and H. H. Kazazian, Jr. 1983. ATA box transcription mutation in beta-thalassemia. Nucleic Acids Res. 11:4727-4733.
39. Picketts, D. J., C. D'Soura, P. J. Bridge, and D. Lillicrap. 1992. An A to T transversion at position -5 of the factor IX promoter results in hemophilia B. Genomics 12:161-163.
40. Picketts, D. J., D. P. Lillicrap, and C. R. Mueller. 1993 Synergy between transcription factors DBP and C/EBP compensates for a hemophilia B Leyden factor IX mutation. Nat. Genet. 3:175-179.
41. Picketts, D. J., C. R. Mueller, and D. P. Lillicrap. 1995. Transcriptional control of the factor IX gene: analysis of five cis-acting elements and the deleterious effects of naturally occurring hemophilia B Leyden mutations. Blood 84:2992-3000.
42. Pittman, D. D., and R. J. Kaufman. 1989. Structure-function relationships of factor VIII elucidated through recombinant DNA technology. Thromb. Haemostasis 61:161-165.
43. Ratnoff, O. D., and J. H. Lewis. 1975. Heckathorn's disease: variable functional deficiency of antihemophilic factor (factor VIII). Blood 46:161-173.
44. Ray, A., M. Hannink, and B. K. Ray. 1995. Concerted participation of NF-kappa B and C/EBP heteromer in lipopolysaccharide induction of serum amyloid A gene expression in liver. J. Biol. Chem. 270:7365-7374.
45. Reijnen, M. J., K. Peerlinck, D. Maasdam, R. M. Bertina, and P. H. Reitsma. 1993. Hemophilia B Leyden: substitution of thymine for guanine at position -21 results in a disruption of a HNF-4 binding site in the factor IX promoter. Blood 82:151-158.
46. Reijnen, M. J., F. M. Sladek, R. M. Bertina, and P. H. Reitsma. 1992. Disruption of a C/EBP binding site for hepatic nuclear factor results in hemophilia B Leyden. Proc. Natl. Acad. Sci. USA 89:6300-6303.
47. Reitsma, P. H., R. M. Bertina, J. K. Ploos van Amstel, A. Riemans, and E. Briet. 1988. The putative factor IX gene promoter in hemophilia B Leyden. Blood 72:1074-1076.
48. Roeder, R. G. 1991. The complexities of eukaryotic transcription initiation: regulation of pre-initiation complex assembly. Trends Biochem. Sci. 16:402-408.
49. Royle, G., N. S. Van De Water, E. Berry, P. A. Ockelford, and P. J. Browett. 1991. Haemophilia B Leyden arising de novo by point mutation in the putative factor IX promoter region. Br. J. Haematol. 77:191-194.
50. Smale, S. T., and D. Baltimore. 1989. The "initiator" as a transcription control element. Cell 57:103-113.
51. Stein, B., and A. S. Baldwin, Jr. 1993. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperatively between C/EBP and NF-KB. Mol Cell. Biol. 13:7191-7198.
52. Svensson, E. C., P. B. Conley, and J. C. Paulson. 1992. Regulated expression of α2,6-sialyltransferase by the liver-enriched transcription factors HNF-1, DBP and LAP. J. Biol. Chem. 267:3466-3472.
53. Toole, J. J., J. L. Knopf, J. M. Wozney, L. A. Sultzman, J. L. Buecker, D. D. Pittman, R. J. Kaufman, E. Brown, C. Shoemaker, E. C. Orr, G. W. Amphlett, W. B. Foster, M. L. Coe, G. J. Knutson, D. N. Pass, and R. M. Hewick. 1984. Molecular cloning of a cDNA encoding human antihaemophilic factor. Nature (London) 312:342-346.
54. Tuddenham, E. G. D., R. Schwaab, J. Seehafer, D. S. Millar, J. Gitschier, M. Higuchi, S. Bidichandani, I. M. Connor, L. W. Hoyer, A. Yoshioka, I. R. Peake, K. Olek, H. H. Kazazian, J.-M. Lavergne, F. Giannelli, S. E. Antonarakis, and D. N. Cooper. 1994. Haemophilia A: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene, second edition. Nucleic Acids Res. 22:4851-4868
55. Vehar, G. A., B. Keyt, D. Eaton, H. Rodriguez, D. P. O'Brien, F. Rothlat, H. Oppermann, R. Keck, W. I. Wood, R. N. Harkins, E. G. D. Tuddenham, R. M. Lawn, and D. J. Capon. 1984. Structure of human factor VIII. Nature (London) 312:337-342.
56. Vuorio, T., S. N. Maity, and B. de Crombrugghe. 1990. Purification and molecular cloning of the A chain of a rat heterodimeric CCAAT-binding protein: sequence identity with the yeast HAP3 transcription factor. J. Biol. Chem. 265:22480-22486.
57. Wieland, K., L.-P. Berg, V. V. Kakkar, D. N. Cooper, and U. Martinowitz. 1990. Molecular genetic analysis of a novel form of haemophilia A characterized by the variable expression of factor VIII. Thromb. Res. 59:871-877.
58. Wion, K. L., D. Kelly, J. A. Summerfield, E. G. D. Tuddenham, and R. M. Lawn. 1985 Distribution of factor VIII mRNA and antigen in human liver and other tissues Nature (London) 317:726-728
59. Wood, W. I., D. J. Capon, C. C. Simonsen, D. L. Eaton, J. Gitschier, B. Keyt, P. H. Seeburg, D. H. Smith, P. Hollingshead, K. L. Wion, E. Delwart, E. G. D. Tuddenham, G. A. Vehar, and R. M. Lawn. 1984. Expression of active human factor VIII from recombinant DNA clones. Nature (London) 312:330-337.
60. Wuarin, J., C. Mueller, and V. Schibler. 1990. A ubiquitous CCAAT factor is required for efficient in vitro transcription from the mouse albumin promoter J Mol. Biol. 214:865-874.